STOCK TITAN
  1. Home
  2. Sec-filings
  3. IQV
  4. [Form 4] IQVIA HOLDINGS INC. Insider Trading Activity

IQVIA (IQV) CEO exercises 50,000 rights and sells shares

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

IQVIA Holdings insider activity: A senior executive reported several stock transactions in IQVIA Holdings Inc. common stock on 12/18/2025. The filing shows an exercise of 50,000 stock appreciation rights at an exercise price of $59.90 per share, resulting in the acquisition of 50,000 shares of common stock.

On the same date, the executive sold 36,564 shares of common stock in open-market transactions at a weighted average price of $222.43 per share, and a further 13,436 shares at $222.91 per share. Following these transactions, the executive directly owned 807,163 shares of IQVIA common stock and indirectly owned 543,302 shares through the Orohena Trust.

Positive

  • None.

Negative

  • None.
Insider BOUSBIB ARI
Role See Remarks
Sold 36,564 shs ($8.13M)
Type Security Shares Price Value
Exercise Stock Appreciation Right 50,000 $59.90 $3.00M
Exercise Common Stock 50,000 $59.90 $3.00M
Sale Common Stock 36,564 $222.43 $8.13M
Disposition Common Stock 13,436 $222.91 $3.00M
holding Common Stock -- -- --
Holdings After Transaction: Stock Appreciation Right — 0 shares (Direct); Common Stock — 857,163 shares (Direct); Common Stock — 543,302 shares (Indirect, By Trust)
Footnotes (1)
  1. Represents the exercise of stock appreciation rights expiring on February 2, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.28 to $222.79, inclusive. Shares held in Orohena Trust.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BOUSBIB ARI
(Last) (First) (Middle)
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD
(Street)
DURHAM NC 27703
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
12/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/18/2025 M 50,000(1) A $59.9 857,163 D
Common Stock 12/18/2025 S 36,564(1) D $222.43(2) 820,599 D
Common Stock 12/18/2025 D 13,436(1) D $222.91 807,163 D
Common Stock 543,302 I By Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right $59.9 12/18/2025 M 50,000 02/02/2020 02/02/2026 Common Stock 50,000 $59.9 0 D
Explanation of Responses:
1. Represents the exercise of stock appreciation rights expiring on February 2, 2026.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.28 to $222.79, inclusive.
3. Shares held in Orohena Trust.
Remarks:
Chairman, Chief Executive Officer & President
/s/ Matthew Gilmartin, Attorney-in-Fact for Ari Bousbib 12/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did IQVIA (IQV) report for 12/18/2025?

The filing reports that a senior IQVIA executive exercised 50,000 stock appreciation rights at an exercise price of $59.90 per share, acquiring 50,000 shares of common stock. On the same day, the executive sold 36,564 shares at a weighted average price of $222.43 and another 13,436 shares at $222.91 per share.

How many IQVIA (IQV) shares does the reporting person own after these transactions?

After the reported transactions on 12/18/2025, the executive directly owned 807,163 shares of IQVIA common stock. In addition, 543,302 shares were indirectly owned through the Orohena Trust.

What type of derivative security did the IQVIA insider exercise?

The insider exercised a stock appreciation right covering 50,000 derivative securities, with a conversion or exercise price of $59.90 per share. These rights were originally exercisable from 02/02/2020 and were set to expire on 02/02/2026, and the exercise resulted in 50,000 shares of common stock.

What prices were received for the IQVIA (IQV) shares sold in this Form 4?

The filing states that 36,564 shares were sold at a weighted average price of $222.43 per share, with individual trades ranging from $222.28 to $222.79, inclusive. An additional 13,436 shares were sold at $222.91 per share.

What is the role of the reporting person at IQVIA Holdings Inc. (IQV)?

The remarks section identifies the reporting person as Chairman, Chief Executive Officer & President of IQVIA Holdings Inc.

How are indirect IQVIA (IQV) shareholdings reported in this Form 4?

The filing shows 543,302 shares of IQVIA common stock reported as indirectly owned, with the nature of indirect beneficial ownership described as By Trust and specifically identified as the Orohena Trust.

Who signed the IQVIA (IQV) Form 4 reporting these insider transactions?

The Form 4 was signed by /s/ Matthew Gilmartin as Attorney-in-Fact for Ari Bousbib on 12/19/2025, indicating that the transactions relate to Ari Bousbib.